The effect of laparoscopic sleeve gastrectomy on metabolic syndrome parameters during one year of follow-up

Abstract

Objective: We aimed to evaluate the effectiveness of laparoscopic sleeve gastrectomy (LSG) as a treatment method for morbid obesity and its impact on reducing the incidence of metabolic syndrome and its components. Patients and Methods: This retrospective and a single-center study included patients with obesity who underwent LSG and were followed up at an endocrinology and metabolism outpatient clinic for at least one year. Anthropometric measurements, blood pressure, and blood examinations including fasting plasma glucose and lipid profile were assessed before the surgery and one year after the surgery. The presence of metabolic syndrome and related comorbidities was documented. Results: The study included 62 patients, with a mean age of 38.2 ± 8 years and a female predominance (88.7%). At one year post-surgery, significant improvements were observed in body weight, waist circumference, blood pressure, and metabolic parameters (P<0.001 for all). The prevalence of metabolic syndrome decreased from 66.1% to 6.5% (P<0.001). The prevalence of diabetes, hypertension, and hepatosteatosis also decreased significantly (P<0.05). Conclusion: Laparoscopic sleeve gastrectomy demonstrates substantial weight loss and positive effects on metabolic syndrome components. The procedure appears to be an effective intervention for obese patients with obesity-related comorbidities. Longer-term prospective studies are needed to further validate these promising results.

Keywords

• Obesity
• Bariatric surgery
• Metabolic syndrome

References

1. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2021; 143:e984-e1010. doi: 10.1161/CIR.000.000.0000000973.
2. Leitner DR, Frühbeck G, Yumuk V, et al. Obesity and type 2 diabetes: two diseases with a need for combined treatment strategies – EASO can lead the way. Obes Facts 2017; 10:483- 92. doi: 10.1159/000480525.
3. Kopp W. How Western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes 2019; 12:2221-36. doi: 10.2147/DMSO.S216791.
4. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics 2015; 33:673-89. doi: 10.1007/ s40273.014.0243-x.
5. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity. Circulation 2009; 120:1640-5. doi: 10.1161/CIRCULATIONAHA.
6. O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev 2015; 16:1-12. doi: 10.1111/obr.12229.
7. Abacı A, Kılıçkap M, Göksülük H, et al. Türkiye’de metabolik sendrom sıklığı verileri: Kardiyovasküler risk faktörlerine yönelik epidemiyolojik çalışmaların sistematik derleme, metaanaliz ve meta-regresyonu [Data on prevalence of metabolic syndrome in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors]. Turk Kardiyol Dern Ars 2018; 46:591-601. Turkish. doi: 10.5543/tkda.2018.00878.
8. Shi X, Karmali S, Sharma AM, Birch DW. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg 2010; 20:1171-7. doi: 10.1007/s11695.010.0145-8.

9. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical Practice Guidelines for medical care of patients with obesity. Endocr Pract 2016;22 Suppl3:1-203. doi: 10.4158/EP161365.GL
10. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-52. doi: 10.1161/CIRCULATIONAHA.105.169404.
11. Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis 2007 ;3:73-7. doi: 10.1016/j.soard.2006.10.017.
12. Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond) 2019; 19:205-12. doi: 10.7861/clinmedicine.19-3-205.
13. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a metaanalysis of US studies. Am J Clin Nutr 2001; 74:579-84. doi: 10.1093/ajcn/74.5.579.
14. Palermo M, Gagner M. Why we think laparoscopic sleeve gastrectomy ıs a good operation: step-by-step technique. J Laparoendosc Adv Surg Tech A 2020; 30:615-18. doi: 10.1089/ lap.2020.0154.
15. Péquignot A, Dhahri A, Verhaeghe P, Desailloud R, Lalau J-D, Regimbeau J-M. Efficiency of laparoscopic sleeve gastrectomy on metabolic syndrome disorders: two years results. J Visc Surg 2012; 149:e350-e5. doi: 10.1016/j. jviscsurg.2012.06.005.
16. Elhag W, El Ansari W, Abdulrazzaq S, Abdullah A, Elsherif M, Elgenaied I. Evolution of 29 anthropometric, nutritional, and cardiometabolic parameters among morbidly obese adolescents 2 years post sleeve gastrectomy. Obes Surg 2018;28:474-82. doi: 10.1007/s11695.017.2868-2.
17. Wojciak PA, Pawłuszewicz P, Diemieszczyk I, et al. Laparoscopic sleeve gastrectomy: a study of efficiency in treatment of metabolic syndrome components, comorbidities and influence on certain biochemical markers. Videosurgery Miniinv 2020; 15:136-47. doi: 10.5114/wiitm.2019.84718.
18. Smeu B, Balescu I, Sarbu A, Fica S, Copaescu C. Early improvement in glycemic metabolism after laparoscopic sleeve gastrectomy in obese patients–a prospective study. Chirurgia (Bucur) 2015; 110:430-9.
19. Graham C, Switzer N, Reso A, et al. Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes. Surg Endosc 2019; 33:3001-7. doi: 10.1007/s00464.018.6566-5.
20. Samson R, Milligan G, Lewine E, et al. Effect of sleeve gastrectomy on hypertension. J Am Soc Hyperten 2018; 12:e19-e25. doi: 10.1016/j.jash.2018.09.007.
21. Sharma C, Platat C, Gariballa S, et al. Metabolomic profiling of lipids and fatty acids: 3 years postoperative laparoscopic sleeve gastrectomy. Biology 2021; 10:298. doi:10.3390/ biology10040298
22. Shabbir A, Dargan D. The success of sleeve gastrectomy in the management of metabolic syndrome and obesity. J Biomed Res 2015; 29:93. doi:10.7555/JBR.28.20140107
23. Salman MA, Salman AA, Omar HS, et al. Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: A prospective study. Surg Endosc 2021; 35:1889-94. doi:10.1007/s00464.020.07725-y.
24. Elyasinia F, Jalali SM, Zarini S, Sadeghian E, Sorush A, Pirouz A. The effect of laparoscopic sleeve gastrectomy and gastric bypass surgery on non-alcoholic steatohepatitis in Iranian patients with obesity. Middle East J Dig Dis 2021; 13:200-207. doi:10.34172/mejdd.2021.226
25. Gagner M, Deitel M, Erickson AL, Crosby RD. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg 2013; 23:2013-7. doi: 10.1007/s11695.013.1040-x.